Home » Topics » BioWorld Science

BioWorld Science
RSS

OncoTherapy Science presents data on OTSA-101 in cervical cancer mouse model

Oct. 5, 2021

Selecta and Takeda enter strategic licensing agreement for lysosomal storage disorders

Oct. 5, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

Oct. 5, 2021

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Oct. 5, 2021

Janpix divulges new STAT5 inhibitors

Oct. 5, 2021

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Oct. 5, 2021

E-Scape Bio discloses LRRK2 inhibitors

Oct. 5, 2021

Genentech patents new TEAD inhibitors

Oct. 5, 2021

Modulating PPM1E is a therapeutic approach in type 2 diabetes

Oct. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...